Universitätsklinikum Carl Gustav Carus Dresden an der Technischen Universität Dresden Anstalt des öffentlichen Rechts des Freistaates Sachsen
ZKN Logo
  • The Center
    • Multiple Sclerosis Center Dresden
      • Patient Information
      • Contact MSC
      • Physicians & Nurses
      • Study Team
      • Neuropsychology
    • Mobility Center
      • The Mobility Center
      • Walking Assessment
      • Jump Assessment
      • DIERS
      • EMIQ
      • Projects
    • Neuroimmunological Laboratory
      • The NIL
      • Neurofilament light chain
    • Autonomic & Neuroendocrinological Functional Laboratory
      • The ANF
      • ANF Assessment
    • MS Living Lab
    • Management & Science
      • Team Management & Science
      • Projects
      • eHealth & Analytics
        • MSDS 3D
        • MSDS Clinic & Practice
        • MS-HRS
        • MTRS
      • Multiple Sclerosis Management
  • Aktuelles
    • Neuigkeiten
    • Publikationen
    • Veranstaltungen
      • Adventssymposium
      • Multiple Sklerose 360°
      • Welt-MS-Tag 2021
    • Doktorarbeiten
    • Jobs
    • Kontakt
  • Podcasts & Newsletter
    • Newsletter
    • Patienten-Podcast
    • Ärzte-Podcast
    • Neurovision
  • Studien
    • Interventionelle Studien
    • B-SHUTTLE
    • Nicht-interventionelle Studien
    • MS PATHS
    • Konectom
    • Sprachanalyse
English (UK)
Deutsch
English (UK)

Treatment of multiple sclerosis with glatiramer acetate - New information about its mechanisms of action, pharmacokinetics, adverse effects and clinical studies

MS Treatments

Jahr

Publikationsjahr
2002

Autoren

Autorenliste der Publikation
Ziemssen T, Neuhaus O, Farina C, Hartung HP, Hohlfeld R.

Verlag

Publisher-Information
Nervenarzt 2002;73(4):321-331.

Link

Zur Publikation (externer Server)
https://link.springer.com/article/10.1007/s00115-001-1257-0

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
MSZTreatments2002

  • MS brain health quality standards: a survey on the reality in clinical practice in Germany

    Multiple Sclerosis
    Jahr
    2024

  • Best supportive care for patients with primary progressive multiple sclerosis (PPMS) in Germany prior to ocrelizumab treatment: Final results from the RETRO PPMS study

    MS Treatments
    Jahr
    2024

  • Harmonized Data Quality Indicators Maintain Data Quality in Long-Term Safety Studies Using Multiple Sclerosis Registries/Data Sources: Experience from the CLARION Study

    Multiple Sclerosis
    Jahr
    2024

  • Eculizumab Use in Neuromyelitis Optica Spectrum Disorders

    MS Treatments
    Jahr
    2024

  • Higher effect sizes for the detection of accelerated brain volume loss and disability progression in multiple sclerosis using deep-learning

    MASC
    Jahr
    2024
  • Start
  • Aktuelles
  • Publikationen
  • MS Treatments
  • Treatment of multiple sclerosis with glatiramer acetate - New information about its mechanisms of action, pharmacokinetics, adverse effects and clinical studies
Impressum & Datenschutz

© 2024
Universitätsklinikum C.G. Carus Dresden an der Technischen Universität Dresden